Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11739-020-02391-3 http://scihub22266oqcxt.onion/10.1007/s11739-020-02391-3 32514682!7278243!32514682     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Intern+Emerg+Med 2020 ; 15 (5): 783-786 Nephropedia Template TP {{tp|p=32514682|t=2020. Managing anticoagulation in the COVID-19 era between lockdown and reopening phases |pdf=|usr=}}{{32514682}} gab.com Text Managing anticoagulation in the COVID-19 era between lockdown and reopening phases JO: Intern Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=32514682 #FOAvip Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. The recent spreadout of the COVID-19 pandemic requires a re-organization of Anticoagulation Clinics to prevent person-to-person viral diffusion and continue to offer the highest possible quality of assistance to patients. In this paper, based on the Italian Federation of Anticoagulation Clinics statements, we offer some advice aimed at improving patient care during COVID-19 pandemic, with particular regard to the lockdown and reopening periods. We give practical guidance regarding the following points: (1) re-thinking the AC organization, (2) managing patients on anticoagulants when they become infected by the virus, (3) managing anticoagulation surveillance in non-infected patients during the lockdown period, and (4) organizing the activities during the reopening phases. Twit Text FOAVip Managing anticoagulation in the COVID-19 era between lockdown and reopening phases ????Intern Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=32514682 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32514682 #FOAvip English Wikipedia <ref>{{Cite pmid|32514682}}</ref> Managing anticoagulation in the COVID-19 era between lockdown and reopening phases #MMPMID32514682 Poli D; Tosetto A; Palareti G; Barcellona D; Ciampa A; Grandone E; Manotti C; Moia M; Squizzato A; Toschi V; Testa S Intern Emerg Med 2020[Aug]; 15 (5): 783-786 PMID32514682show ga Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. The recent spreadout of the COVID-19 pandemic requires a re-organization of Anticoagulation Clinics to prevent person-to-person viral diffusion and continue to offer the highest possible quality of assistance to patients. In this paper, based on the Italian Federation of Anticoagulation Clinics statements, we offer some advice aimed at improving patient care during COVID-19 pandemic, with particular regard to the lockdown and reopening periods. We give practical guidance regarding the following points: (1) re-thinking the AC organization, (2) managing patients on anticoagulants when they become infected by the virus, (3) managing anticoagulation surveillance in non-infected patients during the lockdown period, and (4) organizing the activities during the reopening phases. |*Ambulatory Care Facilities[MESH] |Anticoagulants/*administration & dosage/adverse effects[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/epidemiology[MESH] |Humans[MESH] |Italy/epidemiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/epidemiology[MESH] |Quarantine[MESH] |Risk Factors[MESH]Managing anticoagulation in the COVID-19 era between lockdown and reop(epmc).pdf DeepDyve Pubget Overpricing